Patent foramen ovale: Thromboembolic structure or incidental finding?

Connecticut Medicine

Volumn 75, Issue 2, 2011, Pages 97-105

  Torbey, Estelle ^a   Thompson, Paul D ^b  

^a STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

^b HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ARTICLE; ASYMPTOMATIC DISEASE; HUMAN; INCIDENTAL FINDING; MIGRAINE; OCCLUSIVE CEREBROVASCULAR DISEASE; PATENT FORAMEN OVALE; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVALENCE; RECURRENT DISEASE; RISK FACTOR; SECONDARY PREVENTION; STROKE; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ANTICOAGULANTS; ASYMPTOMATIC DISEASES; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FORAMEN OVALE, PATENT; HUMANS; INCIDENTAL FINDINGS; INTRACRANIAL THROMBOSIS; MIGRAINE DISORDERS; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RECURRENCE; RISK FACTORS; SECONDARY PREVENTION; STROKE; THROMBOEMBOLISM;

EID: 79952058080     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Meissner I, Khandheria BK, Heit JA, et al: Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol2006; 47 (2): 440-5.
2. Lechat P, Mas JL, Lascault G, et al: Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318 (18): 1148-52.
3. Karnik R, S tollberger C, Valentin A, et al: Detection of patent foramen ovale by transcranial contrast Doppler ultrasound. AmJ Cardiol 1992; 69 (5): 560-2.
4. Nedeltchev K, Mattle HP: Contrast-enhanced transcranial Doppler ultrasound for diagnosis of patent foramen ovale. Front NeurolNeurosci 2006; 21: 206-15.
5. Ranoux D, Cohen A, Cabanes L, et al: Patent foramen ovale: is stroke due to paradoxical embolism? Stroke 1993; 24 (1): 31-4.
6. Cheng TO: The proper conduct of Valsalva maneuver in the detection of patent foramen ovale. J Am Coll Cardiol 2005; 45 (7): 1145-6.
7. Krasuski RA: When and how to fix a 'hole in the heart': Approach to ASD and PFO. Cleve Clin J Med 2007; 74 (2): 137-47.
8. Di Tullio M, Sacco RL, Venketasubramanian N, et al: Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke 1993; 24 (7): 1020-4.
9. Daniels C, Weytjens C, Cosyns B, et al: Second harmonic transthoracic echocardiography: the new reference screening method for the detection of patent foramen ovale. Eur J Echocardiogr 2004; 5 (6): 449-52. (Pubitemid 40045651)
10. Hamann GF, Schatzer-Klotz D, Frohlig G, et al: Femoral injection of echo contrast medium may increase the sensitivity of testing for a patent foramen ovale. Neurology 1998; 50 (5): 1423-8. (Pubitemid 28240364)
11. Feigenbaum H: Feigenbaum's echocardiography. In: Armstrong W, Ryan T, editors. 6th ed. Phialdelphia: Lippincott Williams & Wilkins; 2005: 588-9.
12. Hagen PT, Scholz DG, Edwards WD: Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts. Mayo Clin Proc 1984; 59 (1): 17-20.
13. Wechsler LR: PFO and stroke: What are the data? Cardiol Rew 2008; 16 (1): 53-7.
14. Schneider B, Zienkiewicz T, Jansen V, et al: Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings. Am J Cardiol 1996; 77 (14): 1202-9.
15. Arquizan C, Coste J, Touboul PJ, Mas JL: Is patent foramen ovale a family trait? A transcranial Doppler sonographic study. Stroke 2001; 32 (7): 1563-6.
16. Gupta V, Yesilbursa D, Huang WY, et al: Patent foramen ovale in a large population of ischemic stroke patients: Diagnosis, age distribution, gender, and race. Echocardiography 2008; 25 (2): 217-27.
17. Salmasi AM., Salmasi H, Rawlins S, et al: Atrial septal Aneurysm and patent foramen ovale are lessprevalent in the IndoAsian than in the Caucasian or Afro-Caribbean population. Angiology September 2, 2009.
18. Albers GW, Comess KA, DeRook FA, et al: Transesophageal echocardiographic findings in stroke subtypes. Stroke 1994; 25 (1): 23-8.
19. Jeanrenaud X, Bogousslavsky J, Payot M, et al: Patent foramen ovale and cerebral infarct in young patients. Schweiz Med Wochenschr 1990; 120 (22): 823-9.
20. Krasuski RA, Hart SA, Allen D, et al: Prevalence and repair of intraoperatively diagnosed patent foramen ovale and association with perioperative outcomes and long-term survival. JAMA 2009; 302 (3): 290-7.
21. Marchione P, Ghiotto N, Sanees G, et al: Clinical implications of patent foramen ovale in migraine with aura. Funct Neurol 2008; 23 (4): 201-5.
22. Adler E, Love B, Giovannone S, et al: Correlation or causation: Untangling the relationship between patent foramen ovale and migraine. Curr Cardiol Rep 2007; 9 (1): 7-12.
23. Mas JL, Arquizan C, Lamy C, et al: Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345 (24): 1740-6.
24. Konstantinides S, Geibel A, Kasper W, et al: Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation 1998; 97 (19): 1946-51.
25. Handke M, Harloff A, Olschewski M, et al: Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 2007; 357 (22): 2262-8.
26. Homma S, Sacco RL, Di Tullio MR, et al: Effect of medical treatment in stroke patients with patent foramen ovale: Patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002; 105 (22): 2625-31.
27. Di Tullio MR, Sacco RL, Sciacca RR, et al: Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol 2007; 49 (7): 797-802.
28. Jones EF, Kalman JM, Calafiore P, et al: Proximal aortic atheroma. An independent risk factor for cerebral ischemia. Stroke 1995; 26 (2): 218-24.
29. Meissner I, Whisnant JP, Khandheria BK, et al: Prevalence ofpotential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: The SPARC study. Stroke Prevention: Assessment of Riskin a Community. Mayo Clin Proc 1999; 74 (9): 862-9. (Pubitemid 29430352)
30. Wilmshurst PT, Pearson MJ, Walsh KP, et al: Relationship between right-to-left shunts and cutaneous decompression illness. Clin Sci (Lond) 2001; 100 (5): 539-42. (Pubitemid 32434119)
31. Kutty S, Brown K, Qureshi AM, Latson LA: Maximal potential patent foramen diameter does not correlate with the type or frequency of the neurologic event prior to closure. Cardiology 2009; 113 (2): 111-5.
32. Goel SS, Tuzcu EM, Shishehbor MH, et al: Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients. Am J Cardiol 2009; 103 (1): 124-9.
33. Botto N, Spadoni I, Giusti S, et al: Prothrombotic mutations as risk factors for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale. Stroke 2007; 38 (7): 2070-3. (Pubitemid 47012269)
34. Pezzini A, Grassi M, Zotto ED, et al: Do common prothrombotic mutations influence the risk of cerebral ischaemia in patients with patent foramen ovale? Systematic review and meta-analysis. Thromb Haemost 2009; 101 (5): 813-7.
35. Rajamani K, Chaturvedi S, Jin Z, et al: Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as riskfactors for subsequent vascular events: The PICSS-APASS study. Stroke 2009; 40 (7): 2337-42.
36. Rigatelli G, Dell'Avvocata F, Giordan M, et al: Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): Consideration for primary prevention closure? J Interv Cardiol 2009; 22 (4): 398-403.
37. Almekhlafi MA, Wilton SB, Rabi DM, et al: Recurrent cerebral ischemia in medically treated patent foramen ovale: A meta-analysis. Neurology 2009; 73 (2): 89-97.
38. Aggarwal K, Jayam VK, Meyer MA, et al: Thrombus-intransit and paradoxical embolism. J Am Soc Echocardiogr 2002; 15 (9): 1021-2.
39. Koullias GJ, Elefteriades JA, Wu I, et al: Images in cardiovascular medicine. Massive paradoxical embolism: Caught in the act. Circulation 2004; 109 (24): 3056-7. (Pubitemid 38808329)
40. Srivastava TN, Payment MF: Images in clinical medicine. Paradoxical embolism-Thrombus in transit through a patent foramen ovale. N Engl J Med 1997; 337 (10): 681.
41. Thanigaraj S, Zajarias A, Valika A, et al: Caught in the act: Serial, real time images of a thrombus traversing from the right to left atrium across a patent foramen ovale. Eur J Echocardiogr 2006; 7 (2): 179-81. (Pubitemid 43257207)
42. Grosgogeat Y, Lascault G, Artigou JY, et al: Role of patent foramen ovale in the etiology of cerebral embolisms. Bull Mem Acad R Med Belg 1991; 146 (8-10): 356-64.
43. Lethen H, Flachskampf FA, Schneider R, et al: Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol 1997; 80 (8): 1066-9.
44. Stollberger C, Slany J, Schuster I, et al: The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism. Ann Intern Med 1993; 119 (6): 461-5. (Pubitemid 23310106)
45. Cramer SC, Rordorf G, Maki JH, et al: Increased pelvic vein thrombi in cryptogenic stroke: Results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke 2004; 35 (1): 46-50. (Pubitemid 38057588)
46. Mas JL: Diagnosis and management of paradoxical embolism and patent formen ovale. Curr Opin Cardiol 1996; 11 (5): 519-24.
47. Marber MS, de Belder MA, Pumphrey CW, et al: Transoesophageal echocardiography in the diagnosis of paradoxical embolism. Int J Cardiol 1992; 34 (3): 283-8.
48. Langholz D, Louie EK, Konstadt SN, et al: Transesophageal echocardiographic demonstration of distinct mechanisms for right to left shunting across a patent foramen ovale in the absence of pulmonary hypertension. J Am Coll Cardiol 1991; 18 (4): 1112-7.
49. Wu LA, Malouf JF, Dearani JA, et al: Patent foramen ovale in cryptogenic stroke: Current understanding and management options. Arch Intern Med 2004; 164 (9): 950-6.
50. Khairy P, O'Donnell CP, Landzberg MJ: Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: A systematic review. Ann Intern Med 2003; 139 (9): 753-60.
51. Dearani JA, Ugurlu BS, Danielson GK, et al: Surgical patent foramen ovale closure for prevention of paradoxicalembolismrelated cerebrovascular ischemic events. Circulation 1999; 100 (19 Suppl): II171-5.
52. Sukernik MR, Goswami S, Frumento RJ, et al: National survey regarding the management of an intraoperatively diagnosed patent foramen ovale during coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2005; 19 (2): 150-4.
53. Messe SR, Silverman IE, Kizer JR, et al: Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004; 62 (7): 1042-50.
54. Sacco RL, Adams R, Albers G, et al: Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: Co-sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Circulation 2006; 113 (10): e409-49.
55. O'Gara PT, Messe SR, Tuzcu EM, et al: Percutaneous device closure of patent foramen ovale for secondary stroke prevention: A call for completion of randomized clinical trials. A science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2009; 53 (21): 2014-8.
56. Saver J, Caroll J, Smalling R, Thaler D: Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment. In; 2007.
57. Furlan A, Reisman M: A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex® Septal Closure System Versus Best Medical Therapy in Patients with a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism through a Patent Foramen Ovale. In; 2003.
58. Schwerzmann M, Nedeltchev K, Lagger F, et al: Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 2005; 65 (9): 1415-8.
59. Anzola GP, Magoni M, Guindani M, et al: Potential source of cerebral embolism in migraine with aura: A transcranial Doppler study. Neurology 1999; 52 (8): 1622-5. (Pubitemid 29220637)
60. Wilmshurst P, Nightingale S: Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci (Lond) 2001; 100 (2): 215-20. (Pubitemid 32165366)
61. Sztajzel R, Genoud D, Roth S, et al: Patent foramen ovale, a possible cause of symptomatic migraine: A study of 74patients with acute ischemic stroke. Cerebrovasc Dis 2002; 13 (2): 102-6. (Pubitemid 34195679)
62. Rundek T, Elkind MS, Di Tullio MR, et al: Patent foramen ovale and migraine: A cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation 2008; 118 (14): 1419-24.
63. Dowson A, Mullen MJ, Peatfield R, et al: Migraine Intervention With STARFlex Technology (MIST) trial: Aprospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008; 117 (11): 1397-404.
64. Reisman M, Tepper S: MIST II PFO-Migraine Trial with BioSTAR® Bioabsorbable Septal Repair Implant. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US); 2006.
65. Sommer R, Dodick D: Effect of Septal Closure of Atrial PFO on Events of Migraine with Premere: ESCAPE Migraine Trial. In; 2005.
66. Foster PP, Boriek AM, Butler BD, et al: Patent foramen ovale and paradoxical systemic embolism: A bibliographic review. Aviat Space Environ Med 2003; 74 (6 Pt 2): B1-64.
67. Torti SR, Billinger M, Schwerzmann M, et al: Risk of decompression illness among 230 divers in relation to the presence and size of patent foramen ovale. Eur Heart J 2004; 25 (12): 1014-20. (Pubitemid 38869419)
68. Butler BD, Robinson R, Sutton T, Kemper GB: Cardiovascular pressures with venous gas embolism and decompression. Aviat Space Environ Med 1995; 66 (5): 408-14.
69. Bove AA: Risk of decompression sickness with patent foramen ovale. Undersea Hyperb Med 1998; 25 (3): 175-8.
70. Saary MJ, Gray GW: A review of the relationship between patent foramen ovale and type II decompression sickness. Aviat Space Environ Med 2001; 72 (12): 1113-20.
71. Webster MW, Chancellor AM, Smith HJ, et al: Patentforamen ovale in young stroke patients. Lancet 1988; 2 (8601): 11-2.